KA
AVNS icon

Kozak & Associates’s Avanos Medical AVNS Stock Holding History

Kozak & Associates’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99 Hold
4
– – ﹤0.01% 415
2026
Q1 		$58 Hold
4
– – ﹤0.01% 431
2025
Q4 		$49 Hold
4
– – ﹤0.01% 418
2025
Q3 		$44 Buy
+4
New +$47 ﹤0.01% 438

Other funds holding AVNS

SRC
Samson Rock Capital London, United Kingdom $45.6M AUM 86.17% 1-Year Est. Return
CIEC
Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
SIM
SummerHaven Investment Management Stamford, Connecticut $187M AUM 70.61% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Kozak & Associates's AVNS Position: Q2 2026 in Review

Kozak & Associates held its Avanos Medical (AVNS) position steady in Q2 2026 at 4 shares worth $99. The position accounts for ﹤0.01% of the portfolio, ranked #415.

Kozak & Associates first reported a position in AVNS in Q3 2025 and has held it in 4 quarters since. 58 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Kozak & Associates held 4 shares of Avanos Medical worth $99 as of Q2 2026.
  • Kozak & Associates left its Avanos Medical share count unchanged in Q2 2026.
  • Avanos Medical made up ﹤0.01% of Kozak & Associates's portfolio in Q2 2026, its #415 holding.
  • Kozak & Associates first reported a position in Avanos Medical in Q3 2025 and has held it in 4 quarters since.
  • 58 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.